Stoke Therapeutics (STOK) Return on Equity (2022 - 2025)
Historic Return on Equity for Stoke Therapeutics (STOK) over the last 4 years, with Q3 2025 value amounting to 0.13%.
- Stoke Therapeutics' Return on Equity rose 5700.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year increase of 5700.0%. This contributed to the annual value of 0.46% for FY2024, which is 1500.0% up from last year.
- According to the latest figures from Q3 2025, Stoke Therapeutics' Return on Equity is 0.13%, which was up 5700.0% from 0.15% recorded in Q2 2025.
- In the past 5 years, Stoke Therapeutics' Return on Equity ranged from a high of 0.17% in Q1 2025 and a low of 0.72% during Q1 2024
- For the 4-year period, Stoke Therapeutics' Return on Equity averaged around 0.37%, with its median value being 0.51% (2023).
- As far as peak fluctuations go, Stoke Therapeutics' Return on Equity tumbled by -2300bps in 2024, and later surged by 9000bps in 2025.
- Stoke Therapeutics' Return on Equity (Quarter) stood at 0.52% in 2022, then fell by -21bps to 0.63% in 2023, then surged by 39bps to 0.39% in 2024, then surged by 132bps to 0.13% in 2025.
- Its Return on Equity stands at 0.13% for Q3 2025, versus 0.15% for Q2 2025 and 0.17% for Q1 2025.